Please do not leave this page until complete. This can take a few moments.
Natalie Friel is responsible for the growth biomanufterer Resilience in Central Massachusetts.
Parth Chakrabarti is responsible for growing the size, financials, and reach of the UMass Chan research enterprise.
In 1999, when Girish Navani co-founded eClinicalWorks, a healthcare software company hosting patient records, he had a background in robotics but a curiosity about health care and a desire to develop something to help patients and physicians alike.
WPI may be best known for its engineering power, but Debora Jackson is putting the business school on the map in the region.
Cunningham is using his influence as a developer to help communities make the most of what they have.
Definitive Healthcare, a Framingham-based commercial intelligence firm, has launched a new artificial intelligence program to use machine learning to target growth opportunities for its clients.
Milford life sciences equipment manufacturer Waters Corp. is among the top 10 companies in the state for gender diversity in executive leadership.
Cambridge-based drug manufacturer Moderna, Inc. has purchased a 140,000-square-foot biomanufacturing facility at 149 Hayes Memorial Drive in Marlborough.
Marlborough company Sunovion Pharmaceuticals Inc. has begun its in-human clinical trials for a drug to treat generalized anxiety disorder.
Marlborough enterprise IT company OneShield, Inc. named Ken Shapiro as its new chief revenue officer. Shapiro replaces Liza Smith, who is retiring.
Spheric Bio, a Cambridge company developing a 3D heart implant to help prevent strokes, was awarded $50,000 for winning the M2D2 Challenge, a partnership between UMass Chan Medical School and UMass Lowell.
Vince Harris, who founded Marlborough-based Metamagnetics Inc. in 2008, was named CEO of the company, adding to his role as chairman of the board of directors. Lee Burns was promoted to president and chief operating officer.
Developers and brokers are using multiple strategies to bring life sciences companies out past Route 128 in Massachusetts.
Researchers across Central Mass. are leading development of cutting-edge ideas and therapies to provide the next generation of solutions to present and future problems.
The sciences companies in Central Massachusetts that received venture capital funding from 2018 to 2023.
The Massachusetts Biotechnology Council rates the state’s various communities as BioReady based on their ability to host biotechnology facilities.